Citicoline

Citicoline is a neuroprotective agent that promotes brain health by aiding in the synthesis of phosphatidylcholine, a major component of neuronal membranes. CDP-choline is a member of the class of phosphocholines that is the choline ester of CDP. It is an intermediate obtained in the biosynthetic pathway of structural phospholipids in cell membranes. Among its listed roles, it functions as a human metabolite, a psychotropic drug, a neuroprotective agent, a Saccharomyces cerevisiae metabolite and a mouse metabolite. It belongs to the class of phosphocholines and a member of nucleotide-(amino alcohol)s. Functionally, it is related to CDP. It is the conjugate base of CDP-choline(1+). It is grouped under the following drug class(es): Psychotropic agents. Its therapeutic use is listed as alcohol dependence agents and central nervous system (CNS) agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include CDP-Choline, cytidine 5′-diphosphocholine, Difosfocin, Emicholin, Somazina and Meibis. Its PubChem CID is 13804.

CAS No 987-78-0
Molecular Formula C14H26N4O11P2
Molecular Weight 488.32 g/mol
Synonyms [[(2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] 2-(trimethylazaniumyl)ethyl phosphate

Frequently Asked Questions